T1	Participants 77 108	patients with autistic disorder
T2	Participants 331 495	40 children between the ages three and 11 years (inclusive) with a DSM IV clinical diagnosis of autism and who were outpatients from a specialty clinic for children
T3	Participants 656 689	piracetam + risperidone (Group A)
T4	Participants 693 724	placebo + risperidone (Group B)
